Secretaría de Gobernación
CONACYT
INGER
Por favor, use este identificador para citar o enlazar este ítem: http://repositorio.inger.gob.mx/jspui/handle/20.500.12100/17223
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.rights.licensehttp://creativecommons.org/licenses/by/4.0es_MX
dc.creatorDOLORES MINO LEONes_MX
dc.creatorSERGIO SANCHEZ GARCIAes_MX
dc.creatorMARTHA LILIANA GIRALDO RODRIGUEZes_MX
dc.creatorHORTENSIA REYES MORALESes_MX
dc.date2019-
dc.date.accessioned2021-08-24T17:36:12Z-
dc.date.available2021-08-24T17:36:12Z-
dc.identifier.urihttp://repositorio.inger.gob.mx/jspui/handle/20.500.12100/17223-
dc.descriptionPurpose To analyze potentially inappropriate prescribing (PIP), its prevalence and patient conditions associated with this phenomenon, in a cohort of older adults receiving outpatient care in Mexico. Methods Data from 1252 adults ≥ 60 years of age, from primary care centers were analyzed. Information included sociodemographic data, medications, chronic diseases, polypharmacy (≥ 5 medications), functional dependence, cognitive impairment and frailty. Three logistic regression models were employed to identify associations between PIP (according to the Beers criteria) and different variable combinations. Results A total of 41.8% of participants had at least one PIP. The most frequently identified PIPs involved nonsteroidal anti-inflammatory drugs (NSAIDs) and glibenclamide; clonazepam in patients with cognitive impairment; and interactions of warfarin with NSAIDs. In the multivariate analyses, Model 1 showed that frailty and polypharmacy were associated with PIP. In Model 2, only polypharmacy was associated with PIP. For Model 3, lower educational levels, taking hypoglycemics, nervous system disease drugs, antiasthmatics, gastrointestinal disease drugs and anti-inflammatories-antirheumatics and analgesics, were associated with PIP. Conclusion PIP is common in outpatient treatment of health care services in Mexico. Its association with medical and nonmedical factors highlights the need to improve drug treatment quality focused on implementation of effective strategies, such as educative interventions, electronic medication safety alerts, and inclusion of pharmacists in the health team.es_MX
dc.formatAdobe PDFes_MX
dc.languageenges_MX
dc.publisherSpringeres_MX
dc.relationhttps://link.springer.com/article/10.1007/s41999-019-00181-5es_MX
dc.relation.requiresSies_MX
dc.rightsAcceso Abiertoes_MX
dc.sourceEuropean Geriatric Medicine (1878-7657) Vol. 10 (2019)es_MX
dc.subjectMEDICINA Y CIENCIAS DE LA SALUDes_MX
dc.subjectCiencias médicases_MX
dc.subjectCiencias clínicases_MX
dc.subjectGeriatríaes_MX
dc.subjectTerapia medicinales_MX
dc.subjectPrescripción de medicamentoses_MX
dc.subjectPolifarmaciaes_MX
dc.subjectServicios de salud para personas mayoreses_MX
dc.subjectGeriatricses_MX
dc.subjectDrug therapyes_MX
dc.subjectDrug prescriptionses_MX
dc.subjectPolypharmacyes_MX
dc.subjectHealth services for the agedes_MX
dc.titlePotentially inappropriate prescribing to older adults in ambulatory care: prevalence and associated patient conditionses_MX
dc.typeArtículoes_MX
dc.audienceResearcherses_MX
dc.creator.idMILD650803MDFNNL06es_MX
dc.creator.idSAGS710328HDFNRR03es_MX
dc.creator.idGIRM750612MNERDR04es_MX
dc.creator.idREMH510406MDFYRR02es_MX
dc.creator.nameIdentifiercurpes_MX
dc.creator.nameIdentifiercurpes_MX
dc.creator.nameIdentifiercurpes_MX
dc.creator.nameIdentifiercurpes_MX
Aparece en las colecciones: 1. Artículos

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
European Geriatric Medicine (1878-7657) Vol. 10 (2019).pdf626.01 kBAdobe PDFVisualizar/Abrir